Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.
复制标题

DOI:
10.1038/s41591-018-0026-6
复制
发表时间:
2018-07
期刊:
影响因子:
82.9
通讯作者:
RV411 study group
RV411 study group
中科院分区:
医学1区
文献类型:
--
作者:
Colby DJ;Trautmann L;Pinyakorn S;Leyre L;Pagliuzza A;Kroon E;Rolland M;Takata H;Buranapraditkun S;Intasan J;Chomchey N;Muir R;Haddad EK;Tovanabutra S;Ubolyam S;Bolton DL;Fullmer BA;Gorelick RJ;Fox L;Crowell TA;Trichavaroj R;O'Connell R;Chomont N;Kim JH;Michael NL;Robb ML;Phanuphak N;Ananworanich J;RV411 study group

文献摘要

参考文献

被引文献

相似文献

在急性HIV感染(Fiebig I)的最早阶段进行抗逆转录病毒治疗(ART)可能会最大限度地减少潜伏HIV库的建立,从而促进分析性治疗中断(ATI)后的病毒血症控制。我们发现,在Fiebig I期间开始治疗的8名参与者,平均治疗时间为2.8年,在ATI后都经历了快速的病毒载量反弹,这表明需要额外的策略来控制或根除HIV。
Antiretroviral therapy (ART) during the earliest stage of acute HIV infection (Fiebig I) might minimize establishment of a latent HIV reservoir and thereby facilitate viremic control after analytical treatment interruption (ATI). We show that 8 participants, who initiated treatment during Fiebig I and were treated for a median of 2.8 years, all experienced rapid viral load rebound following ATI, indicating that additional strategies are required to control or eradicate HIV.
早期急性HIV感染期间艺术的起源可保留粘膜TH17功能并逆转与HIV相关的免疫激活。
DOI: 10.1371/journal.ppat.1004543
发表时间: 2014-12
期刊: PLoS pathogens
影响因子: 6.7
作者:
Schuetz A;Deleage C;Sereti I;Rerknimitr R;Phanuphak N;Phuang-Ngern Y;Estes JD;Sandler NG;Sukhumvittaya S;Marovich M;Jongrakthaitae S;Akapirat S;Fletscher JL;Kroon E;Dewar R;Trichavaroj R;Chomchey N;Douek DC;O Connell RJ;Ngauy V;Robb ML;Phanuphak P;Michael NL;Excler JL;Kim JH;de Souza MS;Ananworanich J;RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups
通讯作者: RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups
DOI: 10.1038/nm.3109
发表时间: 2013-04
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --
DOI: 10.1038/ncomms9495
发表时间: 2015-10-09
影响因子: 16.6
作者:
Hurst J;Hoffmann M;Pace M;Williams JP;Thornhill J;Hamlyn E;Meyerowitz J;Willberg C;Koelsch KK;Robinson N;Brown H;Fisher M;Kinloch S;Cooper DA;Schechter M;Tambussi G;Fidler S;Babiker A;Weber J;Kelleher AD;Phillips RE;Frater J
通讯作者: Frater J
DOI: 10.1038/nm.4063
发表时间: 2016-04
期刊: Nature medicine
影响因子: 82.9
作者:
Hessell AJ;Jaworski JP;Epson E;Matsuda K;Pandey S;Kahl C;Reed J;Sutton WF;Hammond KB;Cheever TA;Barnette PT;Legasse AW;Planer S;Stanton JJ;Pegu A;Chen X;Wang K;Siess D;Burke D;Park BS;Axthelm MK;Lewis A;Hirsch VM;Graham BS;Mascola JR;Sacha JB;Haigwood NL
通讯作者: Haigwood NL
DOI: 10.1073/pnas.94.24.13193
发表时间: 1997-11-25
影响因子: 11.1
作者:
Chun, TW;Stuyver, L;Fauci, AS
通讯作者: Fauci, AS